Sino Biopharma Invests in Karolinska; Deals Ahead?
November 17, 2014 at 07:08 AM EST
Sino Biopharmaceutical will make an investment of up to $128.5 million in Karolinska Development AB, a Stockholm firm that supports translational drug development in Scandinavia. Typically, Karolinska invests in innovative academic-based concepts, bringing them to a point where they can be partnered. It currently has at least a dozen companies in its portfolio. According to Karolinska, it wanted to have a "strong Asian specialist investor" in life science, with the clear implication that future deals would be made between the two companies. More details.... Stock Symbols: (HK: 1177) (SS: KDEV) Share this with colleagues: // //